University of Iowa Hospitals and Clinics

Category

University of Iowa Hospitals and Clinics Activated as Site for REGN-COV2 Clinical Trial Targeting COVID-19

Clinical investigators at University of Iowa Hospitals and Clinics (UIHC) are participating in a Phase 3 clinical trial investigating Regeneron’s novel monoclonal antibody targeting COVDI-19 known as REGN-COV2. TrialSite News recently showcased this rapidly developed...

Pin It on Pinterest